Tejara Capital Ltd bought a new stake in Albemarle Corporation (NYSE:ALB - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 34,029 shares of the specialty chemicals company's stock, valued at approximately $2,451,000.
Several other hedge funds also recently modified their holdings of ALB. SJS Investment Consulting Inc. acquired a new position in shares of Albemarle during the 1st quarter valued at $32,000. National Pension Service raised its holdings in shares of Albemarle by 74.5% during the first quarter. National Pension Service now owns 452 shares of the specialty chemicals company's stock valued at $33,000 after buying an additional 193 shares during the last quarter. Orion Capital Management LLC bought a new stake in shares of Albemarle during the 4th quarter worth about $35,000. Costello Asset Management INC bought a new stake in shares of Albemarle in the 1st quarter worth $36,000. Finally, Evermay Wealth Management LLC increased its holdings in shares of Albemarle by 84.1% in the first quarter. Evermay Wealth Management LLC now owns 670 shares of the specialty chemicals company's stock valued at $48,000 after buying an additional 306 shares in the last quarter. 92.87% of the stock is owned by institutional investors and hedge funds.
Albemarle Stock Down 3.1%
Shares of Albemarle stock traded down $2.5070 during trading hours on Wednesday, reaching $78.0430. The company's stock had a trading volume of 3,455,643 shares, compared to its average volume of 5,486,469. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.47 and a current ratio of 2.31. The stock's fifty day simple moving average is $70.53 and its two-hundred day simple moving average is $67.98. Albemarle Corporation has a one year low of $49.43 and a one year high of $113.91. The company has a market capitalization of $9.18 billion, a P/E ratio of -8.37 and a beta of 1.63.
Albemarle (NYSE:ALB - Get Free Report) last posted its quarterly earnings results on Wednesday, July 30th. The specialty chemicals company reported $0.11 EPS for the quarter, topping analysts' consensus estimates of ($0.83) by $0.94. Albemarle had a negative net margin of 18.61% and a negative return on equity of 1.87%. The company had revenue of $1.33 billion for the quarter, compared to analysts' expectations of $1.23 billion. During the same quarter in the previous year, the firm posted $0.04 EPS. Albemarle's revenue was down 7.0% on a year-over-year basis. Albemarle has set its FY 2025 guidance at EPS. On average, research analysts forecast that Albemarle Corporation will post -0.04 earnings per share for the current year.
Albemarle Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 1st. Investors of record on Friday, September 12th will be paid a $0.405 dividend. The ex-dividend date of this dividend is Friday, September 12th. This represents a $1.62 annualized dividend and a dividend yield of 2.1%. Albemarle's dividend payout ratio (DPR) is presently -17.38%.
Analysts Set New Price Targets
ALB has been the topic of a number of research reports. JPMorgan Chase & Co. upped their price target on shares of Albemarle from $60.00 to $80.00 and gave the stock a "neutral" rating in a research note on Monday. TD Securities decreased their price target on Albemarle from $115.00 to $65.00 and set a "hold" rating on the stock in a research note on Thursday, May 1st. Scotiabank lifted their price objective on Albemarle from $65.00 to $70.00 and gave the stock a "sector perform" rating in a research report on Friday, August 1st. KeyCorp restated a "sector weight" rating on shares of Albemarle in a report on Wednesday, July 30th. Finally, Baird R W cut Albemarle from a "hold" rating to a "strong sell" rating in a report on Tuesday, July 29th. Three analysts have rated the stock with a Buy rating, nine have given a Hold rating and five have issued a Sell rating to the company. According to MarketBeat, the company currently has an average rating of "Reduce" and an average target price of $89.17.
Get Our Latest Analysis on ALB
About Albemarle
(
Free Report)
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.
Read More

Before you consider Albemarle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Albemarle wasn't on the list.
While Albemarle currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.